Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain

Abstract

Recombinant AAV is increasingly becoming the vector of choice for many gene therapy applications in the CNS, due to its lack of toxicity and high level of sustained expression. With recent improvements in the generation of pure, high titer vector stocks, the regulation of gene expression is now a key issue for successful translation of gene therapy-based treatments to the clinic. The level of the transgene protein may need to be maintained within a narrow therapeutic window for the successful treatment of human disease. The doxycycline responsive system directs a dose-responsive, tightly regulated level of gene expression and has been used successfully in transgenic mouse models. Here, we have optimized an autoregulatory, bidirectional doxycyline responsive cassette specifically for use in rAAV. We minimized the size of the cassette and decreased the basal leakiness of the system, leading to tight regulation in the rat brain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Reed Clark K et al. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses Hum Gene Ther 1999 10: 1031–1039

    Article  Google Scholar 

  2. Monahan PE, Samulski RJ . AAV vectors: is clinical success on the horizon? Gene Therapy 2000 7: 24–30

    Article  CAS  PubMed  Google Scholar 

  3. Constantini LC, Bakowska JC, Breakfield XO, Isacson O . Gene therapy in the CNS Gene Therapy 2000 7: 93–109

    Article  Google Scholar 

  4. Navarro V et al. Efficient gene transfer and long term expression in neurons using a recombinant adenovirus with a neuron specific promoter Gene Therapy 1999 6: 1884–1892

    Article  CAS  PubMed  Google Scholar 

  5. Peel AL, Klein RL . AAV vectors: activity and applications in the CNS J Neurosci Meth 2000 98: 85–104

    Article  Google Scholar 

  6. Bjorklund A et al. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model Brain Res 2000 886: 82–98

    Article  CAS  PubMed  Google Scholar 

  7. Shen Y et al. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase aromatic-L-amino-acid decarboxylase and GTP cyclohydrolase I for gene therapy of Parkinson's disease Hum Gene Ther 2000 11: 1509–1519

    Article  CAS  PubMed  Google Scholar 

  8. During MJ et al. In vivo expression of the therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector Gene Therapy 1998 5: 820–827

    Article  CAS  PubMed  Google Scholar 

  9. Rudich SM et al. Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoetin in monkeys J Surg Res 2000 90: 102–108

    Article  CAS  PubMed  Google Scholar 

  10. Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc Natl Acad Sci USA 1992 89: 5547–5551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Rivera VM et al. A humanized system for pharmacological control of gene expression Nat Med 1996 2: 1028–1032

    Article  CAS  PubMed  Google Scholar 

  12. Strathdee CA, McLeod MR, Hall JR . Efficient control of tetracycline-responsive gene expression from an autoregulated bidirectional expression vector Gene 1999 229: 21–29

    Article  CAS  PubMed  Google Scholar 

  13. Loeb JE et al. Enhanced expression of transgenes from adeno-associated vectors with the woodchuck post-transcriptional regulatory element: importance for gene therapy Hum Gene Ther 1999 10: 2295–2305

    Article  CAS  PubMed  Google Scholar 

  14. Flotte TR et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter J Biol Chem 1993 268: 3781–3790

    CAS  PubMed  Google Scholar 

  15. Bell AC, West AG, Felsenfeld G . The protein CTCF is required for the enhancer blocking activity of vertebrate insulators Cell 1999 98: 387–396

    Article  CAS  PubMed  Google Scholar 

  16. Gallia GL, Khalili K . Evaluation of an autoregulatory tetracycline regulated system Oncogene 1998 16: 1879–1884

    Article  CAS  PubMed  Google Scholar 

  17. Baron U, Gossen M, Bujard H . Tetracycline-controlled transcription in eukaryotes: novel transactivator with graded transactivation potential Nucleic Acids Res 1997 25: 2723–2729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Baron U, Gossen M, Bujard H . Tetracycline-controlled transcription in eukaryotes: novel transactivator with graded transactivation potential

  19. Mastakov MY et al. Combined injection of rAAV with mannitol enhances gene expression in the rat brain Mol Ther 2001 3: 225–232

    Article  CAS  PubMed  Google Scholar 

  20. Haberman RP, McCown TJ, Samulski RJ . Inducible long-term expression in brain with adeno-associated virus gene transfer Gene Therapy 1998 5: 1604–1611

    Article  CAS  PubMed  Google Scholar 

  21. Bohl D, Salvetti A, Moullier P, Heard JM . Control of erythropoietin by doxycycline in mice after intramuscular injection of adeno-associated vector Blood 1998 92: 1512–1517

    CAS  PubMed  Google Scholar 

  22. Freundlieb S, Schirra-Mueller C, Bujard H . A tetracycline controlled activation/repression system with increased potential in gene transfer into mammalian cells J Gen Med 1999 1: 4–12

    Article  CAS  Google Scholar 

  23. Nakai H, Storm TA, Kay MA . Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors Nat Biotechnol 2000 18: 527–532

    Article  CAS  PubMed  Google Scholar 

  24. Duan D, Yue Y, Yan Z, Engelhardt JF . A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation Nat Med 2000 6: 595–598

    Article  CAS  PubMed  Google Scholar 

  25. Sun L, Li J, Xiao X . Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerisation Nat Med 2000 6: 599–602

    Article  CAS  PubMed  Google Scholar 

  26. Kistner A et al. Doxycycline-mediated quantitative and tissue specific control of gene expression in transgenic mice Proc Natl Acad Sci USA 1996 93: 10933–10938

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank R Bland, D Young and T Lawlor for critical reading of the manuscript. We are grateful to C Strathdee for providing the pBIG3r plasmid. This work was supported by the New Economy Research Fund, New Zealand Health Research Council, the National Institutes of Health and the Jefferson Faculty Foundation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fitzsimons, H., McKenzie, J. & During, M. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther 8, 1675–1681 (2001). https://doi.org/10.1038/sj.gt.3301582

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301582

Keywords

This article is cited by

Search

Quick links